Jingjun Cheng, MD, PhD, is the Medical Safety Director and Global Pharmacovigilance Physician at Genmab, specializing in the safety monitoring of clinical development programs across various therapeutic fields, including oncology and nephrology. With over 17 years of experience in the (bio)pharmaceutical industry, they have held senior positions in translational medicine and pharmacovigilance. Prior positions include roles at Byondis, Takeda, and Synthon, as well as a postdoctoral research fellowship at the Netherlands Institute for Neuroscience. Cheng has contributed to the EFPIA's Pharmacovigilance Expert Group and served as a Director of Pharmacovigilance at AM-Pharma.
This person is not in the org chart
This person is not in any teams
This person is not in any offices